Late diagnosis means that people with pancreatic cancer may never receive treatment and don’t get the chance to have life saving treatment and live longer.
As a leading voice of the pancreatic cancer community, we work with governments, clinicians, researchers and those affected by the disease across the UK to find ways to improve and speed up diagnosis and develop faster and better treatment for pancreatic cancer – and call for more investment in research.
Pancreatic cancer won’t wait, and we won’t stop campaigning for ways to transform the future for those affected by the disease.
The Department for Health and Social Care has declared a new ‘War on Cancer’, as part of which they launched a survey asking for our ideas to write its new 10-year cancer plan.
We have submitted a response, and helped more than 200 of our supporters to submit their own responses, too.
Together, we’ve called for the Government to prioritise increasing pancreatic cancer survival rates in their new 10-year cancer plan.
Right now thousands of people with pancreatic cancer don’t have access to a simple prescription that could stop them starving. We’re calling on the NHS to prescribe what people with the quickest killing cancer urgently need to live the time they have left to the fullest. Will you sign our open letter?
Our No Time to Wait campaign called on local NHS services across the UK to give everyone with pancreatic cancer the best chance of survival, and ensure that no one was left waiting for vital treatment. Find out how we made people with pancreatic cancer a national priority during the pandemic.
We believe it’s about time that people with pancreatic cancer should be diagnosed early enough to be saved.
Doctors should have a simple test to help them detect pancreatic cancer in time for treatment.
Getting people into treatment quickly gives them a chance to survive and for longer. That’s why we demand that people with pancreatic cancer receive faster treatment, within 20 days from diagnosis.
Governments, strategies and plans have consistently missed the opportunity to target the necessary research investment into pancreatic cancer that’s required to transform survival. That’s why we believe now is the time to invest in pancreatic cancer research.
When governments, charities and the clinical community come together to prioritise pancreatic cancer and other less survivable and historically neglected cancers, survival can be transformed.